198 related articles for article (PubMed ID: 2155783)
1. An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.
Rosenbaum H; Harris AW; Bath ML; McNeall J; Webb E; Adams JM; Cory S
EMBO J; 1990 Mar; 9(3):897-905. PubMed ID: 2155783
[TBL] [Abstract][Full Text] [Related]
2. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
3. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.
Largaespada DA; Kaehler DA; Mishak H; Weissinger E; Potter M; Mushinski JF; Risser R
Oncogene; 1992 Apr; 7(4):811-9. PubMed ID: 1565479
[TBL] [Abstract][Full Text] [Related]
4. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.
Engelman A; Rosenberg N
Mol Cell Biol; 1990 Aug; 10(8):4365-9. PubMed ID: 2164639
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of myc-related oncogene mRNA characterizes most BALB/c plasmacytomas induced by pristane or Abelson murine leukemia virus.
Mushinski JF; Bauer SR; Potter M; Reddy EP
Proc Natl Acad Sci U S A; 1983 Feb; 80(4):1073-7. PubMed ID: 6302668
[TBL] [Abstract][Full Text] [Related]
6. Molecular requirements for rapid plasmacytoma and pre-B lymphoma induction by Abelson murine leukemia virus in myc-transgenic mice.
Sugiyama H; Wang Y; Jackson P; Sawyers CL; Klein G
Int J Cancer; 1994 Jul; 58(1):135-41. PubMed ID: 8014009
[TBL] [Abstract][Full Text] [Related]
7. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
8. Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas.
Weissinger EM; Mischak H; Goodnight J; Davidson WF; Mushinski JF
Mol Cell Biol; 1993 Apr; 13(4):2578-85. PubMed ID: 8455630
[TBL] [Abstract][Full Text] [Related]
9. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
[TBL] [Abstract][Full Text] [Related]
10. Rapid induction of plasmacytomas in mice by pristane and a murine recombinant retrovirus containing an avian v-myc and a defective raf oncogene.
Potter M; Wax J; Mushinski E; Brust S; Babonits M; Wiener F; Mushinski JF; Mezebish D; Skurla R; Rapp U
Curr Top Microbiol Immunol; 1986; 132():40-3. PubMed ID: 3792042
[No Abstract] [Full Text] [Related]
11. Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus.
Ohno S; Migita S; Wiener F; Babonits M; Klein G; Mushinski JF; Potter M
J Exp Med; 1984 Jun; 159(6):1762-77. PubMed ID: 6202819
[TBL] [Abstract][Full Text] [Related]
12. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations.
Ohno S; Migita S; Murakami S
Oncogene; 1989 Dec; 4(12):1513-7. PubMed ID: 2687771
[TBL] [Abstract][Full Text] [Related]
13. Induction of plasmacytomas secreting antigen-specific monoclonal antibodies with a retrovirus expressing v-abl and c-myc.
Weissinger EM; Mischak H; Largaespada DA; Kaehler DA; Mitchell T; Smith-Gill SJ; Risser R; Mushinski JF
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8735-9. PubMed ID: 1924333
[TBL] [Abstract][Full Text] [Related]
14. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
Rosson D; Reddy EP
Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
[TBL] [Abstract][Full Text] [Related]
15. Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.
Shore SK; Bogart SL; Reddy EP
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6502-6. PubMed ID: 2168550
[TBL] [Abstract][Full Text] [Related]
16. Structures and activities of activated abl oncogenes.
Risser R; Holland GD
Curr Top Microbiol Immunol; 1989; 147():129-53. PubMed ID: 2695292
[No Abstract] [Full Text] [Related]
17. An E. coli expression system for the rapid purification and characterization of a v-abl tyrosine protein kinase.
Lydon NB; Adams B; Poschet JF; Gutzwiller A; Matter A
Oncogene Res; 1990; 5(3):161-73. PubMed ID: 2157186
[TBL] [Abstract][Full Text] [Related]
18. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
Chen YY; Wang LC; Huang MS; Rosenberg N
Genes Dev; 1994 Mar; 8(6):688-97. PubMed ID: 7926759
[TBL] [Abstract][Full Text] [Related]
19. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas.
Adams JM; Gerondakis S; Webb E; Corcoran LM; Cory S
Proc Natl Acad Sci U S A; 1983 Apr; 80(7):1982-6. PubMed ID: 6572957
[TBL] [Abstract][Full Text] [Related]
20. Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.
Colledge WH; Gebhardt A; Edge MD; Bell JC
Oncogene; 1989 Jun; 4(6):753-7. PubMed ID: 2543944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
